期刊文献+

血浆蛋白C、抗凝血酶Ⅲ在2型糖尿病肾病患者中的活性变化 被引量:1

原文传递
导出
摘要 目的观察血浆蛋白c(Pc)、抗凝血酶Ⅲ(AT-Ⅲ)在2型糖尿病肾病(DN)各期的水平,探讨其在DN发生与发展的作用。方法检测30例正常人和84例2型糖尿病(DM)患者PC、AT-Ⅲ水平。根据24h尿蛋白定量(UAE)将患者分为4组:单纯DM组(UAE〈15mg/24h)20例;A组:尿白蛋白正常组(UAE15~30mg/24h)22例;B组:微量尿白蛋白组(UAE30—300mg/24h)21例;C组:大量尿白蛋白组(UAE〉300mg/24h)21例。结果DM各组血浆Pc水平高于正常对照组,AT-Ⅲ活性低于正常对照组,差异均有统计学意义(均P〈0.05);在DM无并发症时即出现上述改变。结论DM患者存在血管内皮损伤,血液高凝状态,Pc、AT-Ⅲ在一定程度上可反映DM凝血功能变化,并能反映DN的发生和发展,与UAE联合监测有助于早期诊断DN。
作者 赵海燕
出处 《中国卫生工程学》 CAS 2013年第5期425-425,427,共2页 Chinese Journal of Public Health Engineering
  • 相关文献

参考文献6

  • 1Alberti KG, Zimmet PZ. Defnition, diagnosis and classify - cation of diabetes mellitus and it s complications. Part I : diagnosis and classification of diabetes mellitus provision - al report of a WHO consulation[ J]. Diabet Med, 1998,15:535.
  • 2McLaren M, Elhadd TA, Greene SA, et al. Elevatedplasma vascu- lar endothelial cell growth factor and throm - bomodulin in juven- ile diabetic patients[ J]. Clin Appl Thromb Hemost, 1999,5 ( 1 ) : 21 - 24.
  • 3Boffa MC, Karochkine M, Berard M. Plasma thrombo2modulin as a marker of endothelium damage [ J ]. Nouv RevFr Hematol, 1991, 33(6) :529 -530.
  • 4Blann AD ,Lip GY. Hypothesis:is soluble P2selectin anew marker of platelet activation Atherosclerosis [J]. 1997,128 ( 2 ) : 135 - 138.
  • 5郑彤,肖纯,何军,陈念祖,刘洪斌.2型糖尿病患者凝血变化的试验分析[J].中华检验医学杂志,2002,25(5):290-292. 被引量:28
  • 6杜林林,王朝晖.P选择素在急性冠状动脉综合征中的研究进展[J].临床心血管病杂志,2003,19(7):442-444. 被引量:34

二级参考文献13

  • 1Blake G J, Ridker P M. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89: 763--771.
  • 2Libby P. Changing concepts of atherogenesis. J Internal Med, 2000, 247: 349--358.
  • 3Kabbani S S, Watkins M W, Holoch P A, et al. Platelet reactivity in coronary ostial blood: A reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy. J Thromb Thrombolysis, 2001,12: 171--176.
  • 4Atalar E, Aytemir K, Haznedaroglu I, et al. Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol, 2001, 78:69--73.
  • 5Kayikcioglu M, Can L, Meto-Erdem N, et al. Soluble p-selectin and the success of thrombolysis in acute myocardial infarction. Int J Cardiol, 2001,79: 223--229.
  • 6Itoh T, Nakai K, Ono M, et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker p-selectin?Coron Artery Dis, 1995,6: 645--650.
  • 7Crea F, Biasucci L M, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol, 1997, 80(5A): 10E--16E.
  • 8Merten M, Thiagarajan P. P-selectin expression on platelet determines size and stability of platelet aggregates. Circulation, 2000,102: 1931--1936.
  • 9Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction.Thromb Res, 2001, 104: 197--205.
  • 10Bienvenu J G, Tanguay J F, Theore J F, et al. Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation,2001, 103: 1128--1134.

共引文献57

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部